Morgan Cantley, PharmD, BCOP
Advertisement
Articles by Morgan Cantley, PharmD, BCOP
Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan.
Advertisement
Latest Updated Articles
Trastuzumab and HER2-Targeted Therapy: Breaking Down the BasicsPublished: August 15th 2025 | Updated:
- Expert Highlights Advances in HER2-Directed Therapies Beyond HER2-Positive Disease
Published: August 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5